Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ASO Visual Abstract: Multidisciplinary Tumor Board Documentation-Assessing its Frequency, Quality, and Impact.

Annals of surgical oncology·2026
Same author

Multidisciplinary Tumor Board Documentation: Assessing its Frequency, Quality, and Impact.

Annals of surgical oncology·2026
Same author

CRISPR-Based Gene Dependency Screens Reveal Mechanism of BRAF Inhibitor Resistance in Anaplastic Thyroid Cancer.

Molecular carcinogenesis·2026
Same author

Workforce growth without reach: National trends in access to high-volume parathyroid surgeons.

Surgery·2026
Same author

Succinate dehydrogenase-deficient cancer cells have increased susceptibility to Ym155-induced DNA damage.

Endocrine-related cancer·2026
Same author

Utilization of thyroid ultrasound and surgery after glucagon-like peptide-1 receptor agonist prescription.

Surgery·2026

Related Experiment Video

Updated: Dec 22, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.7K

Genetic testing in endocrine surgery: Opportunities for precision surgery.

Wilson Alobuia1, Justin Annes2, Electron Kebebew1

  • 1Department of Surgery and Stanford Cancer Institute, Stanford University School of Medicine, CA.

Surgery
|May 8, 2020
PubMed
Summary

Genetic testing is crucial for diagnosing and managing hereditary endocrine disorders in surgical patients. Understanding tumor susceptibility genes aids in personalized patient care and surgical decisions.

More Related Videos

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.5K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.2K

Related Experiment Videos

Last Updated: Dec 22, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.7K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.5K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.2K

Area of Science:

  • Endocrinology
  • Genomic Medicine
  • Surgical Oncology

Background:

  • Advances in molecular and genetic diagnostics are transforming genomic medicine.
  • Hereditary endocrine disorders are prevalent in endocrine surgery.
  • Genetic factors significantly influence endocrine surgical conditions.

Purpose of the Study:

  • To review inherited endocrine disorders and their associated tumor susceptibility genes.
  • To highlight the clinical utility of genetic testing in endocrine surgery.
  • To examine the impact of genetic testing on surgical management.

Main Methods:

  • Literature review of inherited endocrine disorders.
  • Analysis of tumor susceptibility genes in endocrine surgery.
  • Evaluation of the clinical relevance of genetic testing.

Main Results:

  • Genetic testing is integral to diagnosing and managing endocrine surgical disorders.
  • Identification of specific genes aids in risk stratification and personalized treatment.
  • Genetic information influences surgical planning and patient counseling.

Conclusions:

  • Genetic testing is an essential tool for endocrine surgeons.
  • Integrating genetic insights improves patient outcomes in hereditary endocrine conditions.
  • Further research into genetic associations will refine surgical strategies.